Drug Type Small molecule drug |
Synonyms 5-Isopropyl-2-methyl-1,4-benzoquinone |
Target |
Action inhibitors |
Mechanism Mitochondrial proteins inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC10H12O2 |
InChIKeyKEQHJBNSCLWCAE-UHFFFAOYSA-N |
CAS Registry490-91-5 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Prostate Carcinoma | Preclinical | Japan | 30 Apr 2025 |





